Grant: Operating Grant - Priority Announcement: Infection and Immunity (Bridge Funding)
McGill University
$100,000.00
Aminopeptidases of malaria parasites: understanding their biochemistry, structure and function for new drug development
FY 2010-11
Summary
Malaria remains one of the most serious infections of humans worldwide. Over 3 billion people are at risk of infection with
this parasite and 2-3 million die each year, mainly children under the age of five. Due to the global spread of drug resistant
malaria our armoury of drugs available to combat this disease is seriously reduced. Moreover, there is no vaccines available
or in sight. Accordingly, there is an urgent need for us to identify and characterise new parasite targets at which we can
develop new drugs. We have identified enzymes called 'aminopeptidase' in malaria parasites that we have shown have great potential for new drugs. Here we will study the biochemistry, structure and function of these enzymes to forge a new path
towards the design of a new class of anti-malarial treatment.
Department
Program
Operating Grant - Priority Announcement: Infection and Immunity (Bridge Funding)
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
220040
Name
Dalton John P
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Microbiology & Infectious Diseases
Projecttitle
Aminopeptidases of malaria parasites: understanding their biochemistry, structure and function for new drug development
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - Priority Announcement: Infection and Immunity (Bridge Funding)
Keyworddelim
Aminopeptidases; Biochemistry; Cellular Biology; Enzymology; Malaria; Protein Characterisation
Abstract
Malaria remains one of the most serious infections of humans worldwide. Over 3 billion people are at risk of infection with
this parasite and 2-3 million die each year, mainly children under the age of five. Due to the global spread of drug resistant
malaria our armoury of drugs available to combat this disease is seriously reduced. Moreover, there is no vaccines available
or in sight. Accordingly, there is an urgent need for us to identify and characterise new parasite targets at which we can
develop new drugs. We have identified enzymes called 'aminopeptidase' in malaria parasites that we have shown have great potential for new drugs. Here we will study the biochemistry, structure and function of these enzymes to forge a new path
towards the design of a new class of anti-malarial treatment.
Competitiondate
201009
Approvedterm2
1 yr 0 mth
Pinamesdelim
Dalton, John P
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~